# Agilera Pharma – FDA Inspection, Dec 1, 2017

Source: https://www.keypedia.com/records/fda_inspections/agilera-pharma/07ddeb21-8ce2-48cc-a842-3672191eafa9
Source feed: FDA_Inspections

> FDA inspection 1035520 of Agilera Pharma, December 01, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1035520
- Company Name: Agilera Pharma
- Inspection Date: 2017-12-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1203671 - 2023-03-24
- FDA Inspection 956443 - 2016-01-12
- FDA Inspection 822657 - 2013-03-12
- [FDA Inspection 651395 - 2010-02-19](https://www.keypedia.com/records/fda_inspections/agilera-pharma/ee1d48af-d86d-453b-aa8e-315f37d82d34)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/patric-c-klotzbuecher/cbb2e6b5-b001-457e-9073-33535f02926e)

Company: https://www.keypedia.com/companies/agilera-pharma/3a658db3-8a35-4930-ba81-c106a13df5da

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c